Drug Benefit News: PBMs Look to the Future

Drug Benefit News: PBMs Look to the Future

Mark Merritt, President and CEO, PCMA, predicts that PBMs will assume a more clinical focus as drugs continue to be more complex. “PBMs have been at the forefront of utilization data and, as genomics leads to more personalized medicine, we can provide claims data,” he said.